A.R.T. Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18,631
Closed -$846K 1188
2019
Q4
$846K Sell
18,631
-4,300
-19% -$203K 0.04% 629
2019
Q3
$1.05M Buy
+22,931
New +$1.29M 0.05% 528
2019
Q1
Sell
-6,429
Closed -$250K 1730
2018
Q4
$250K Buy
+6,429
New +$252K 0.02% 991
2018
Q2
Sell
-24,729
Closed -$976K 1885
2018
Q1
$976K Sell
24,729
-18,900
-43% -$735K 0.04% 676
2017
Q4
$1.48M Buy
+43,629
New +$1.24M 0.07% 478
2017
Q2
Sell
-23,804
Closed -$347K 1833
2017
Q1
$347K Buy
23,804
+8,294
+53% +$123K 0.02% 947
2016
Q4
$220K Buy
15,510
+12,860
+485% +$199K 0.01% 1034
2016
Q3
$46K Buy
+2,650
New +$43.9K 0.01% 596
2016
Q1
Sell
-5,183
Closed -$98K 1744
2015
Q4
$98K Buy
+5,183
New +$106K ﹤0.01% 1330
2015
Q1
Sell
-35,119
Closed -$1.22M 1783
2014
Q4
$1.22M Buy
35,119
+22,230
+172% +$902K 0.05% 562
2014
Q3
$541K Buy
+12,889
New +$575K 0.03% 716
2014
Q1
Sell
-16,246
Closed -$950K 1632
2013
Q4
$950K Buy
16,246
+7,995
+97% +$418K 0.05% 499
2013
Q3
$434K Buy
+8,251
New +$554K 0.02% 836

Other funds holding ARNA

A.R.T. Advisors's ARNA Position: Q1 2020 in Review

A.R.T. Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 18,631 shares — an estimated $846K sold.

A.R.T. Advisors first reported a position in ARNA in Q3 2013 and held it in 13 quarters. The position peaked at $1.48M in Q4 2017. 218 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • A.R.T. Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 18,631 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $846K.
  • A.R.T. Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 13 quarters.
  • A.R.T. Advisors's Arena Pharmaceuticals Inc position peaked at $1.48M in Q4 2017.
  • 218 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.